Triple Combination Therapy (ARNI, SGLT2i, MRA) in Advanced HFpEF

Conditions

• HFpEF
• LVDD
• Myocardial Fibrosis

Interventions

• DRUG: [ARNI + SGLTi + AMR]
• DRUG: [SGLTi + previously taken RAAS blocker]

Sponsor

National Medical Research Center for Cardiology, Ministry of Health of Russian Federation

Collaborators

• [object Object]